The PPJ Gazette - November 3, 2014 With alarming frequency, foster and health care providers are turning to a risky but convenient remedy to control the…
Where do parents and teachers get the idea there’s “something wrong” with their kid and only an expensive drug can fix it? From Pharma’s seamless web of ads, subsidized doctors, journals, medical courses and conferences, paid “patient” groups, phony public services messages and reporters willing to serve as stenographers.
Johnson & Johnson, the company that makes the antipsychotic drug Risperdal, has tentatively agreed to a settlement of $2.2 billion to resolve a federal investigation into the company’s marketing practices.
This weekend, there’s going to be an Occupy day of protest and rallies in Philadelphia—but not by Occupy Philly. On Saturday, activists will come from all over the country for Occupy the APA, a peaceful day of action to protest the new edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V), which is being rolled out at the annual meeting of the American Psychiatric Association (APA) at the Convention Center. Unlike other protests that sometimes divide the mental health advocacy community, this protest will include people from diverse constituencies—from psychiatrists and those who take medications to psychiatric “survivors” who believe psychiatry is dangerously abusive.
Australia – THE number of children aged six and under being prescribed anti-depressants has soared by almost 50 per cent since the federal government pledged to investigate the issue, new figures show.
Federal health department data reveals prescribing rates of the controversial drugs have risen from 852 in 2007-08 to 1264 in 2009-10.
But despite Health Minister Nicola Roxon ordering an investigation three years ago, a Freedom of Information request shows the government held just two meetings.
Australian Childhood Foundation chief executive Dr Joe Tucci said he would have expected the government to act by now. “I cannot think of a good reason why any six-year-old, or younger, should be treated with antidepressants,” he said. “I think it’s gone up because medication is being used to treat the symptoms and not the cause.”